Stockscreener 앱 받기
0.455
1.54%
0.0069
시간 외 거래:
.45
-0.005
-1.10%
Inspiremd Inc 주식(NSPR)의 최신 뉴스
InspireMD (NSPR) Climbs 8.5% to $0.52 as Shares Reclaim the $0.50 LevelButterfly Setup - https://www.siam.in/
InspireMD (NSPR) Climbs 8.5% to $0.52 as Shares Reclaim the $0.50 LevelMomentum Trade - https://www.dars.gov.et/
InspireMD (NASDAQ:NSPR) Will Have To Spend Its Cash Wisely - Simply Wall Street
Form 4 InspireMD Inc For: 27 September By Investing.com - Investing.com UK
Form 4 InspireMD Inc For: 27 September By Investing.com - Investing.com Nigeria
Form 4 InspireMD Inc For: 26 September By Investing.com - Investing.com Nigeria
Form 4 InspireMD Inc For: 26 September By Investing.com - Investing.com UK
Director Stuka Paul reports acquiring and disposing of two warrant series at InspireMD (NSPR). - Stock Titan
InspireMD (NSPR) director Gary S. Roubin acquired and disposed of warrants with different exercise prices. - Stock Titan
InspireMD amends certain Series J, Series K warrants - Medical Buyer
Lake Street Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $4 - Moomoo
InspireMD (NASDAQ: NSPR) Revises Series J and K Warrants with $0.7674 Exercise Price and FDA-Linked Expiry by May 2028 - kalkinemedia.com
InspireMD Amends Warrants for Up to $11 Million Tied to FDA Approval - Minichart
InspireMD amends warrants tied to FDA approval timeline By Investing.com - Investing.com South Africa
InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million - manilatimes.net
InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million - GlobeNewswire Inc.
An anticipated FDA approval could open up $11 million for InspireMD's stroke-prevention device. - Stock Titan
InspireMD amends warrants tied to FDA approval timeline - Investing.com
InspireMD amends warrants tied to FDA approval timeline By Investing.com - Investing.com Canada
InspireMD amends warrants tied to FDA approval timeline By Investing.com - Investing.com UK
InspireMD approves 221,666 share inducement grant for new hire - scanx.trade
Full Transcript: InspireMD Q2 2026 Earnings Call - Benzinga
InspireMD announces inducement grants - Medical Buyer
Inspiremd Stock Price Forecast. Should You Buy NSPR? - StockInvest.us
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
InspireMD Inc. (NSPR) Key Financial Ratios – Valuation, Profitability & More - Value Research
InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference - marketscreener.com
InspireMD Inc. (NSPR) Peer Comparison – Compare with Others - valueresearchonline.com
InspireMD Inc. Series B Warrants (NSPRZ) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
InspireMD Inc (NSPR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
InspireMD Inc. Series B Warrants (NSPRZ) Peer Comparison – Compare with Others - Value Research
InspireMD Earnings Call: Recall Pain, Regulatory Potential - TipRanks
InspireMD Inc. Series B Warrants (NSPRZ) Key Financial Ratios – Valuation, Profitability & More - Value Research
InspireMD Inc. (NSPR) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
InspireMD (NSPR) Drops 4.65% to $0.89 as Key Support at $0.85 Comes into FocusETF Creation Redemption - siam.in
InspireMD (NSPR) Drops 4.65% to $0.89 as Key Support at $0.85 Comes into FocusStandard Deviation - dars.gov.et
Maxim Group Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $3 - Moomoo
InspireMD (NSPR) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
InspireMD Q2 2026 Earnings: Revenue Misses $1.77 Million Estimate - Sci-Tech Today
Maxim Group Maintains InspireMD(NSPR.US) With Buy Rating, Cuts Target Price to $3 - Moomoo
Lake Street Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $4 - Moomoo
InspireMD total revenue down 0.4% to USD 1,771,000 in Q2 2026 - Medical Buyer
Form 8K InspireMD Inc For: 17 August By Investing.com - Investing.com South Africa
InspireMD Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
InspireMD Q2 revenue holds at $1.8 million - grafa.com
InspireMD, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
InspireMD Releases Q2 2026 Financial Results - AlphaStreet
Earnings call transcript: InspireMD Q2 2026 revenue miss weighs on shares - Investing.com Nigeria
Earnings call transcript: InspireMD Q2 2026 revenue miss weighs on shares - Investing.com
8.76%
12.34%
자본화:
|
볼륨(24시간):